[The effect of hormonal therapy on the breast in the climacteric syndrome in women].
The author observed three groups of women during their receiving hormonal therapy for the climacteric syndrome. They underwent clinical investigation, mammography and thermography. The first group (n = 31) received 10 mg estradiolmonobenzoate every 6 weeks, the second group (n = 33) 2.5 mg estradiolmonobenzoate and 50 mg testosteroneisobutyrate every 6 weeks. The control group (n = 50) received no hormonal therapy. According to the results obtained, no statistically significant changes were observed following the hormonal therapy.
D001940:Breast / Q000187:drug effects*; D002979:Climacteric; D004958:Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008327:Mammography; D008875:Middle Aged; D013577:Syndrome; D013739:Testosterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013817:Thermography
D013739:Testosterone; D004958:Estradiol; C028499:testosterone isobutyrate
Utjecaj hormonskog lijecenja klimaktericnog sindroma zena na dojke.